The impact of omega-3 fatty acid supplementation on glycemic control in patients with gestational diabetes: a systematic review and meta-analysis of randomized controlled studies
Authors:
- 29 October 2018
- journal article
- review article
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 33 (10) , 1767-1773
Abstract
Background: Omega-3 fatty acid supplementation shows some treatment efficacy for gestational diabetes. This systematic review and meta-analysis is conducted to investigate the efficacy of omega-3 fatty acid supplementation for glycemic control in patients with gestational diabetes. Methods: The databases including PubMed, Embase, Web of science, EBSCO, and Cochrane Library databases are systematically searched for collecting the randomized controlled trials (RCTs) regarding the efficacy of omega-3 fatty acid versus placebo for gestational diabetes. Results: This meta-analysis has included seven RCTs. Compared with placebo group in patients with gestational diabetes, omega-3 fatty acids supplementation results in remarkably reduced fasting plasma glucose (FPG) (standard mean difference (std. MD) = −0.56; 95% confidence interval (CI) = −0.87 to −0.24; p = 0.0005), homeostatic model of assessment for insulin resistance (HOMA-IR) (std. MD = −0.52; 95% CI = −0.83 to −0.21; p = 0.001), but has no statistical impact on macrosomia (risk ratio (RR) = 0.48; 95% CI = 0.22–1.02; p = 0.06), newborns’ hyperbilirubinemia (RR = 0.46; 95% CI = 0.19–1.10; p = 0.08), nitric oxide (NO) (std. MD = 0.17; 95% CI = −0.64–0.98; p = 0.68), preterm delivery (RR = 1.75; 95% CI = 0.08–3.80; p = 0.16) and preeclampsia (RR = 0.74; 95% CI = 0.26–2.16; p = 0.59). However, notably decreased high sensitivity C-reactive protein (hs-CRP) is revealed after omega-3 fatty acids supplementation (std. MD = −1.14; 95% CI = −2.0 to −0.29; p = 0.009). Conclusions: Omega-3 fatty acids supplementation can provide substantially beneficial effects on glycemic control and inflammatory response for gestational diabetes.Keywords
Funding Information
- National Natural Science Foundation of China (81601304)
This publication has 33 references indexed in Scilit:
- Lactation intensity and fasting plasma lipids, lipoproteins, non-esterified free fatty acids, leptin and adiponectin in postpartum women with recent gestational diabetes mellitus: The SWIFT cohortMetabolism, 2014
- Fish-oil supplementation in pregnancy does not reduce the risk of gestational diabetes or preeclampsiaThe American Journal of Clinical Nutrition, 2012
- Cytokine profile, metabolic syndrome and cardiovascular disease risk in women with late-onset gestational diabetes mellitusCytokine, 2012
- Arterial stiffness, inflammatory and pro-atherogenic markers in gestational diabetes mellitusVasa, 2012
- The Role of Inflammatory Cytokines in Diabetes and Its ComplicationsJournal of Periodontology, 2008
- Decreased cord blood IL-4, IL-13, and CCR4 and increased TGF-β levels after fish oil supplementation of pregnant womenJournal of Allergy and Clinical Immunology, 2008
- CLA and n-3 PUFA differentially modulate clinical activity and colonic PPAR-responsive gene expression in a pig model of experimental IBDClinical Nutrition, 2006
- Effect of docosahexaenoic acid and eicosapentaenoic acid supplementation on oxidative stress levels during pregnancyFree Radical Research, 2006
- Chemistry and biology of vitamin EMolecular Nutrition & Food Research, 2004
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996